Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-18
DOI
10.3389/fimmu.2021.657803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac allograft vasculopathy: Insights on pathogenesis and therapy
- (2020) Felicity Lee et al. CLINICAL TRANSPLANTATION
- Surveillance for Cardiac Allograft Vasculopathy: Practice Variations Among 50 Pediatric Heart Transplant Centers
- (2020) Deipanjan Nandi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection
- (2020) Tengfang Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis
- (2019) Jessica C. Garbern et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiac Allograft Vasculopathy
- (2019) Chetan B. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
- (2019) Mithun Khattar et al. PLoS One
- Conflicting vascular and metabolic impact of the IL-33/sST2 axis
- (2018) Raffaele Altara et al. CARDIOVASCULAR RESEARCH
- IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation
- (2018) Kelei Cao et al. Journal of Neuroinflammation
- The Past, Present and Future of Heart Transplantation
- (2018) In-Cheol Kim et al. Korean Circulation Journal
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4+Foxp3+ T cells in concordant heart transplantation
- (2016) Chen Dai et al. LABORATORY INVESTIGATION
- HMGB1 Is Involved in Chronic Rejection of Cardiac Allograft via Promoting Inflammatory-Like mDCs
- (2014) H. Zou et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model
- (2011) Naoyuki Kimura et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Chronic cardiac allograft rejection: critical role of ED-A+fibronectin and implications for targeted therapy strategies
- (2011) Marcus Franz et al. JOURNAL OF PATHOLOGY
- Interleukin-33 prolongs allograft survival during chronic cardiac rejection
- (2011) Stefan M. Brunner et al. TRANSPLANT INTERNATIONAL
- IL-33 Prolongs Murine Cardiac Allograft Survival Through Induction of TH2-Type Immune Deviation
- (2010) Hui Yin et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now